Currently, no long-term human studies exist , but BPC-157 has shown no signs of organ damage or hormonal suppression in months-long rodent studies
This is higher than the 6% seen with the 2.4 mg dose
Yes, reduced saliva can increase risk of tooth decay and gum disease, making good oral hygiene and regular dental visits especially important
Also, rare redness, minor pain, and a headache may accompany the treatment
Method development/assay validation : Standardized peptides used as controls or probes to confirm detection methods (e.g., identity-linked sequences in documentation)
The UK SmPC acknowledges that some patients may require a slower titration schedule or may need to remain at a lower maintenance dose of 1.7 mg if 2.4 mg is not tolerated